Intensive management of diabetes is identified as a critical component of inpatient care. However, the fundamental question that remains is whether controlling glycemia in noncritically ill diabetes patients at the lower end of the current guidelines improves outcomes of hospitalization, long-term outcomes of the primary condition, and long-term outcomes of diabetes compared with average glycem...

Objective Tight glycemic control and aggressive treatment of additional cardiovascular risk factors can substantially reduce risk of diabetes-related complications. In 2013, the Swiss Society of Endocrinology and Diabetology (SSED) established national criteria on good disease management in diabetes, but little is known about compliance in clinical care. Here we assessed to what extent patients...

Lister Hill Auditorium National Institutes of Health Bethesda, Maryland, USA Co-Sponsors: American Dietetic Association American Society for Clinical Nutrition Centers for Disease Control and Prevention Department of Defense Fogarty International Center Food and Drug Administration/Center for Food Safety & Applied Nutrition National Institute of Dental and Craniofacial Research National Institu...

The article for the first time in domestic science systematizes history of formation and development Ukrainian centers study creativity heritage outstanding teacher writer A. Makarenko. It is emphasized that Ukraine an integral important part world Makarenko studies process, it has been at origins this area research remained one its driving forces many years.The independent center was a formed ...

OBJECTIVES To develop and validate a self-efficacy measure of diabetes self-management, the Lifestyle Self-Efficacy Scale for Latinos with Diabetes (LSESLD), designed for low-income, Spanish-speaking Latinos with diabetes. DESIGN Quantitative and qualitative methods. SETTING Community health centers in central and western Massachusetts. PARTICIPANTS Low-income Latinos (N = 252) enrolled i...

OBJECTIVE To investigate diabetes-specific autoantibodies and additional autoimmune phenomena in a large cohort of young patients with type 1 diabetes. RESEARCH DESIGN AND METHODS Data from 28,671 patients <30 years with type 1 diabetes from 242 specialized centers in Germany and Austria were analyzed. RESULTS At least one beta-cell antibody was present in 81.6% of patients. beta-cell-Ab-ne...